Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARTT: Romosozumab in tibial fracture
NCT00907296Phase 2Completed
- Sponsor
- Amgen
- Start
- Sep 2009
- Primary completion
- Mar 2012
- Modality
- Monoclonal Antibodies
- Countries
- 23
01
Overview
A Phase 2 trial of romosozumab in tibial fracture, sponsored by Amgen. Started Sep 2009; status: completed.
02
Drugs
romosozumab
03
Conditions
tibial fracture
Beyond the preview
Go deeper on NCT00907296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907296.